Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 68 | 2024 | 5143 | 3.980 |
Why?
|
p21-Activated Kinases | 2 | 2018 | 128 | 1.120 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2024 | 8519 | 1.070 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 3 | 2018 | 83 | 0.820 |
Why?
|
Sp1 Transcription Factor | 2 | 2014 | 140 | 0.810 |
Why?
|
Waldenstrom Macroglobulinemia | 5 | 2021 | 1073 | 0.760 |
Why?
|
Acrylamides | 3 | 2018 | 259 | 0.660 |
Why?
|
Mesenchymal Stem Cells | 3 | 2024 | 1636 | 0.580 |
Why?
|
Cell Line, Tumor | 33 | 2024 | 16945 | 0.560 |
Why?
|
Transcriptional Activation | 3 | 2014 | 1753 | 0.560 |
Why?
|
Mice, SCID | 19 | 2018 | 2625 | 0.550 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 105 | 0.540 |
Why?
|
Cell Survival | 13 | 2018 | 5790 | 0.490 |
Why?
|
Cell Proliferation | 21 | 2023 | 10425 | 0.480 |
Why?
|
Aminopyridines | 1 | 2018 | 570 | 0.470 |
Why?
|
Antineoplastic Agents | 13 | 2024 | 13616 | 0.450 |
Why?
|
Enhancer Elements, Genetic | 2 | 2018 | 1363 | 0.420 |
Why?
|
Neoplasm, Residual | 2 | 2021 | 1008 | 0.390 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2014 | 586 | 0.340 |
Why?
|
Plasma Cells | 4 | 2018 | 599 | 0.320 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5778 | 0.320 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2024 | 5292 | 0.320 |
Why?
|
Oncogenes | 4 | 2021 | 1223 | 0.320 |
Why?
|
Xenograft Model Antitumor Assays | 15 | 2024 | 3590 | 0.310 |
Why?
|
Immunotherapy | 3 | 2024 | 4649 | 0.300 |
Why?
|
RNA Splicing | 3 | 2019 | 915 | 0.290 |
Why?
|
Bone Marrow Cells | 9 | 2024 | 2416 | 0.290 |
Why?
|
Apoptosis | 14 | 2022 | 9468 | 0.290 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2018 | 287 | 0.280 |
Why?
|
Mice | 37 | 2024 | 81402 | 0.280 |
Why?
|
Cytokines | 4 | 2018 | 7377 | 0.270 |
Why?
|
Leukocytes, Mononuclear | 4 | 2023 | 1841 | 0.260 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1649 | 0.260 |
Why?
|
Translocation, Genetic | 4 | 2021 | 1388 | 0.260 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2023 | 1314 | 0.250 |
Why?
|
Rad51 Recombinase | 2 | 2018 | 189 | 0.240 |
Why?
|
Animals | 41 | 2024 | 168253 | 0.240 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3874 | 0.240 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9176 | 0.230 |
Why?
|
Cell Cycle | 2 | 2011 | 2929 | 0.230 |
Why?
|
B-Cell Maturation Antigen | 2 | 2023 | 149 | 0.220 |
Why?
|
Stem Cell Transplantation | 3 | 2022 | 1598 | 0.220 |
Why?
|
B-Lymphocytes | 2 | 2016 | 4748 | 0.220 |
Why?
|
MicroRNAs | 4 | 2023 | 3796 | 0.220 |
Why?
|
Osteoclasts | 5 | 2013 | 711 | 0.210 |
Why?
|
Syndecan-1 | 2 | 2017 | 163 | 0.210 |
Why?
|
Dexamethasone | 7 | 2023 | 1944 | 0.210 |
Why?
|
DNA Damage | 4 | 2018 | 2441 | 0.210 |
Why?
|
Interleukin-6 | 5 | 2012 | 3209 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5662 | 0.200 |
Why?
|
Hydroxamic Acids | 3 | 2016 | 481 | 0.200 |
Why?
|
Boronic Acids | 6 | 2013 | 914 | 0.200 |
Why?
|
RNA, Small Interfering | 7 | 2017 | 3428 | 0.200 |
Why?
|
Interleukin-15 | 1 | 2023 | 185 | 0.200 |
Why?
|
Caspases | 5 | 2018 | 876 | 0.200 |
Why?
|
Stromal Cells | 9 | 2024 | 1330 | 0.190 |
Why?
|
Bone Marrow | 8 | 2021 | 2907 | 0.190 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2202 | 0.180 |
Why?
|
Pyrazines | 6 | 2013 | 1199 | 0.180 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2023 | 11729 | 0.180 |
Why?
|
Humans | 76 | 2024 | 760437 | 0.170 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2024 | 1135 | 0.170 |
Why?
|
Tumor Cells, Cultured | 9 | 2020 | 6128 | 0.170 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2023 | 653 | 0.170 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2024 | 633 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2024 | 1404 | 0.170 |
Why?
|
14-3-3 Proteins | 1 | 2020 | 221 | 0.160 |
Why?
|
Transcription Factor DP1 | 1 | 2018 | 136 | 0.160 |
Why?
|
STAT3 Transcription Factor | 3 | 2014 | 870 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 1 | 2024 | 1075 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2024 | 988 | 0.160 |
Why?
|
NAD | 2 | 2013 | 614 | 0.160 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 178 | 0.160 |
Why?
|
Immunologic Factors | 2 | 2023 | 1588 | 0.160 |
Why?
|
Heavy Chain Disease | 1 | 2018 | 19 | 0.150 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2018 | 62 | 0.150 |
Why?
|
Prognosis | 5 | 2018 | 29551 | 0.150 |
Why?
|
RNA Precursors | 1 | 2019 | 212 | 0.150 |
Why?
|
Nuclear Factor 45 Protein | 1 | 2017 | 5 | 0.150 |
Why?
|
Alternative Splicing | 1 | 2022 | 1091 | 0.150 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2018 | 410 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3631 | 0.140 |
Why?
|
Sulfonamides | 2 | 2024 | 1973 | 0.140 |
Why?
|
Polyadenylation | 1 | 2018 | 117 | 0.140 |
Why?
|
Interleukin-17 | 2 | 2015 | 907 | 0.140 |
Why?
|
bcl-X Protein | 1 | 2018 | 410 | 0.140 |
Why?
|
Transcription Factors | 6 | 2024 | 12121 | 0.140 |
Why?
|
Osteoblasts | 4 | 2013 | 1143 | 0.140 |
Why?
|
Thalidomide | 3 | 2019 | 885 | 0.140 |
Why?
|
Neoplasm Transplantation | 4 | 2016 | 2014 | 0.140 |
Why?
|
Azepines | 1 | 2018 | 329 | 0.140 |
Why?
|
Protein Binding | 3 | 2018 | 9340 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1530 | 0.140 |
Why?
|
RNA Interference | 2 | 2018 | 2832 | 0.130 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 3610 | 0.130 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2018 | 179 | 0.130 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2011 | 774 | 0.130 |
Why?
|
Histone Deacetylases | 3 | 2016 | 719 | 0.130 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2017 | 375 | 0.130 |
Why?
|
Gene Expression Profiling | 9 | 2018 | 9410 | 0.130 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 2017 | 0.130 |
Why?
|
Genome, Human | 2 | 2019 | 4423 | 0.130 |
Why?
|
Polymers | 1 | 2023 | 1615 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2012 | 472 | 0.130 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 749 | 0.130 |
Why?
|
Paraproteinemias | 1 | 2018 | 248 | 0.130 |
Why?
|
Allosteric Regulation | 1 | 2017 | 426 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2012 | 476 | 0.120 |
Why?
|
Introns | 1 | 2018 | 981 | 0.120 |
Why?
|
Cyclophilin A | 1 | 2015 | 58 | 0.120 |
Why?
|
Oligonucleotides | 1 | 2018 | 582 | 0.120 |
Why?
|
Oligonucleotides, Antisense | 1 | 2018 | 461 | 0.120 |
Why?
|
Antibodies | 2 | 2017 | 2421 | 0.120 |
Why?
|
Oligopeptides | 1 | 2020 | 1186 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 150 | 0.120 |
Why?
|
Protein Subunits | 1 | 2018 | 942 | 0.120 |
Why?
|
MAP Kinase Signaling System | 3 | 2015 | 1485 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1233 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2014 | 2423 | 0.110 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 612 | 0.110 |
Why?
|
Cell Movement | 6 | 2024 | 5198 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2024 | 2895 | 0.110 |
Why?
|
Protein Multimerization | 1 | 2018 | 982 | 0.110 |
Why?
|
Cell Death | 3 | 2014 | 1664 | 0.110 |
Why?
|
Triazoles | 1 | 2018 | 903 | 0.110 |
Why?
|
Melphalan | 3 | 2023 | 420 | 0.110 |
Why?
|
Sirtuins | 1 | 2015 | 320 | 0.110 |
Why?
|
Cell Adhesion | 5 | 2011 | 3088 | 0.100 |
Why?
|
Flow Cytometry | 2 | 2021 | 5865 | 0.100 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2018 | 710 | 0.100 |
Why?
|
Alleles | 2 | 2021 | 6908 | 0.100 |
Why?
|
Osteolysis | 2 | 2012 | 275 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1771 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3800 | 0.090 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 855 | 0.090 |
Why?
|
beta Catenin | 2 | 2015 | 1040 | 0.090 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1463 | 0.090 |
Why?
|
MAP Kinase Kinase 2 | 2 | 2010 | 92 | 0.090 |
Why?
|
Genomics | 4 | 2019 | 5806 | 0.090 |
Why?
|
Endoribonucleases | 1 | 2012 | 228 | 0.090 |
Why?
|
Mice, Nude | 1 | 2017 | 3603 | 0.090 |
Why?
|
SUMO-1 Protein | 1 | 2009 | 35 | 0.090 |
Why?
|
Remission Induction | 1 | 2015 | 2394 | 0.090 |
Why?
|
Piperidines | 3 | 2013 | 1656 | 0.080 |
Why?
|
Neuroblastoma | 1 | 2018 | 1250 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1889 | 0.080 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2010 | 331 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3445 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2009 | 69 | 0.080 |
Why?
|
Gene Targeting | 1 | 2012 | 838 | 0.080 |
Why?
|
Survival Rate | 6 | 2021 | 12698 | 0.080 |
Why?
|
Maytansine | 1 | 2009 | 86 | 0.080 |
Why?
|
Plasmids | 1 | 2014 | 2274 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 614 | 0.080 |
Why?
|
Quinazolinones | 1 | 2010 | 221 | 0.080 |
Why?
|
Activins | 1 | 2010 | 210 | 0.080 |
Why?
|
NF-kappa B | 2 | 2014 | 2485 | 0.080 |
Why?
|
Disease-Free Survival | 4 | 2022 | 6813 | 0.080 |
Why?
|
Melanoma, Experimental | 1 | 2011 | 559 | 0.080 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 687 | 0.080 |
Why?
|
Niacinamide | 1 | 2010 | 413 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2805 | 0.070 |
Why?
|
Signal Transduction | 7 | 2021 | 23397 | 0.070 |
Why?
|
Transplantation, Autologous | 2 | 2023 | 2113 | 0.070 |
Why?
|
B-Cell Activating Factor | 1 | 2007 | 115 | 0.070 |
Why?
|
Enzyme Inhibitors | 3 | 2012 | 3710 | 0.070 |
Why?
|
Drug Synergism | 4 | 2016 | 1755 | 0.070 |
Why?
|
Etodolac | 1 | 2006 | 19 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1610 | 0.070 |
Why?
|
Purines | 1 | 2010 | 605 | 0.070 |
Why?
|
Cytotoxins | 1 | 2007 | 153 | 0.070 |
Why?
|
Immunoblotting | 4 | 2012 | 1647 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2413 | 0.070 |
Why?
|
Catechin | 1 | 2006 | 69 | 0.070 |
Why?
|
Cell Differentiation | 5 | 2015 | 11526 | 0.070 |
Why?
|
Autophagy | 3 | 2024 | 1319 | 0.060 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2009 | 621 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2016 | 2978 | 0.060 |
Why?
|
Mutation | 7 | 2021 | 30025 | 0.060 |
Why?
|
Bone Regeneration | 1 | 2008 | 432 | 0.060 |
Why?
|
Male | 20 | 2024 | 360035 | 0.060 |
Why?
|
Antigens, Surface | 1 | 2009 | 1608 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 973 | 0.060 |
Why?
|
Phosphorylation | 3 | 2010 | 8311 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2008 | 753 | 0.060 |
Why?
|
GTP Phosphohydrolases | 2 | 2020 | 516 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2020 | 1745 | 0.060 |
Why?
|
Receptors, Immunologic | 2 | 2014 | 1411 | 0.060 |
Why?
|
Stress, Physiological | 1 | 2011 | 1400 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2024 | 285 | 0.060 |
Why?
|
Proteins | 2 | 2023 | 6033 | 0.060 |
Why?
|
Calreticulin | 1 | 2024 | 114 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 9598 | 0.050 |
Why?
|
Acetylation | 2 | 2016 | 1054 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2013 | 1942 | 0.050 |
Why?
|
Disease Progression | 3 | 2022 | 13484 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2821 | 0.050 |
Why?
|
Osteogenesis | 1 | 2009 | 1273 | 0.050 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2009 | 1355 | 0.050 |
Why?
|
Benzimidazoles | 1 | 2007 | 855 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 2007 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1646 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1974 | 0.050 |
Why?
|
Immunoconjugates | 1 | 2009 | 953 | 0.050 |
Why?
|
Membrane Proteins | 5 | 2021 | 7849 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2012 | 3592 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2020 | 4108 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9267 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2010 | 2860 | 0.050 |
Why?
|
Mitochondrial Proteins | 1 | 2006 | 979 | 0.040 |
Why?
|
Doxorubicin | 2 | 2018 | 2215 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2013 | 18955 | 0.040 |
Why?
|
Kinetics | 2 | 2018 | 6377 | 0.040 |
Why?
|
Pyrimidines | 1 | 2012 | 3024 | 0.040 |
Why?
|
Cell Communication | 1 | 2007 | 1652 | 0.040 |
Why?
|
Protein Biosynthesis | 1 | 2007 | 2114 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2020 | 267 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2006 | 2870 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 243 | 0.040 |
Why?
|
Bone and Bones | 1 | 2009 | 2566 | 0.040 |
Why?
|
Down-Regulation | 3 | 2012 | 2911 | 0.040 |
Why?
|
Genetic Vectors | 2 | 2021 | 3392 | 0.040 |
Why?
|
Germinal Center | 1 | 2021 | 380 | 0.040 |
Why?
|
Chromatin | 2 | 2023 | 2951 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2024 | 7597 | 0.040 |
Why?
|
Nuclear Respiratory Factor 1 | 1 | 2018 | 21 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2018 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2013 | 427 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3777 | 0.040 |
Why?
|
Ubiquitin | 1 | 2023 | 838 | 0.040 |
Why?
|
Transplantation, Heterologous | 4 | 2007 | 2385 | 0.040 |
Why?
|
Female | 16 | 2024 | 391875 | 0.040 |
Why?
|
Transduction, Genetic | 1 | 2021 | 901 | 0.040 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2017 | 41 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2013 | 2468 | 0.040 |
Why?
|
Multiprotein Complexes | 2 | 2015 | 1119 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2018 | 270 | 0.040 |
Why?
|
Gene Expression | 3 | 2018 | 7582 | 0.040 |
Why?
|
Chromosomes, Human | 1 | 2019 | 442 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 64591 | 0.040 |
Why?
|
DNA Repair | 2 | 2017 | 2044 | 0.040 |
Why?
|
Sequence Analysis, Protein | 1 | 2018 | 258 | 0.030 |
Why?
|
Exons | 1 | 2022 | 2392 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2006 | 2163 | 0.030 |
Why?
|
Genes, myc | 1 | 2018 | 390 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2018 | 678 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2272 | 0.030 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2015 | 39 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 659 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2018 | 515 | 0.030 |
Why?
|
Coculture Techniques | 2 | 2012 | 1340 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 4567 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2007 | 2224 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1059 | 0.030 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2018 | 374 | 0.030 |
Why?
|
Mutagens | 1 | 2015 | 179 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 997 | 0.030 |
Why?
|
Substrate Specificity | 1 | 2019 | 1792 | 0.030 |
Why?
|
Clone Cells | 1 | 2018 | 1660 | 0.030 |
Why?
|
Lymphotoxin-beta | 1 | 2014 | 14 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6330 | 0.030 |
Why?
|
Blotting, Western | 2 | 2013 | 5031 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2023 | 1897 | 0.030 |
Why?
|
Point Mutation | 1 | 2019 | 1595 | 0.030 |
Why?
|
Genomic Instability | 1 | 2018 | 709 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 1824 | 0.030 |
Why?
|
Early Growth Response Protein 1 | 1 | 2014 | 132 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1218 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10759 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3782 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2023 | 4936 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 184 | 0.030 |
Why?
|
Gene Amplification | 1 | 2018 | 1086 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2217 | 0.030 |
Why?
|
Cell Line | 3 | 2013 | 15598 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 435 | 0.030 |
Why?
|
DNA Replication | 1 | 2019 | 1418 | 0.030 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 138 | 0.020 |
Why?
|
Aged | 7 | 2020 | 168840 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1739 | 0.020 |
Why?
|
Phylogeny | 1 | 2019 | 2806 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2453 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2011 | 18216 | 0.020 |
Why?
|
Benzoquinones | 1 | 2012 | 198 | 0.020 |
Why?
|
Integrin alpha4 | 1 | 2011 | 87 | 0.020 |
Why?
|
Neovascularization, Pathologic | 2 | 2012 | 2642 | 0.020 |
Why?
|
eIF-2 Kinase | 1 | 2012 | 145 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1738 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2326 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2012 | 126 | 0.020 |
Why?
|
RNA, Messenger | 3 | 2013 | 12785 | 0.020 |
Why?
|
Ligands | 2 | 2009 | 3270 | 0.020 |
Why?
|
Lysine | 1 | 2015 | 992 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2011 | 384 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 577 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9462 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2013 | 450 | 0.020 |
Why?
|
Middle Aged | 7 | 2020 | 220382 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2012 | 318 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 733 | 0.020 |
Why?
|
Androstadienes | 1 | 2012 | 348 | 0.020 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2009 | 30 | 0.020 |
Why?
|
Adult | 6 | 2022 | 220781 | 0.020 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 234 | 0.020 |
Why?
|
Receptors, Interleukin-17 | 1 | 2010 | 80 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2018 | 2137 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4849 | 0.020 |
Why?
|
Smad2 Protein | 1 | 2010 | 145 | 0.020 |
Why?
|
Umbilical Veins | 1 | 2010 | 426 | 0.020 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2009 | 68 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3818 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2012 | 1230 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3486 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2009 | 148 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6042 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 200 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2009 | 352 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 1052 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8522 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 441 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2047 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22097 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9309 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 960 | 0.020 |
Why?
|
Fibronectins | 1 | 2011 | 723 | 0.020 |
Why?
|
Acid Phosphatase | 1 | 2007 | 139 | 0.020 |
Why?
|
Organ Specificity | 1 | 2012 | 1956 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1890 | 0.020 |
Why?
|
Receptors, Laminin | 1 | 2006 | 26 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 2007 | 153 | 0.020 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2007 | 186 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 986 | 0.020 |
Why?
|
Lentivirus | 1 | 2009 | 508 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2006 | 293 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2010 | 897 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1741 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 211 | 0.020 |
Why?
|
Transgenes | 1 | 2009 | 1009 | 0.020 |
Why?
|
Molecular Mimicry | 1 | 2006 | 213 | 0.020 |
Why?
|
RANK Ligand | 1 | 2007 | 318 | 0.020 |
Why?
|
Histones | 1 | 2015 | 2577 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2014 | 1891 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10075 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2006 | 276 | 0.020 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2004 | 38 | 0.020 |
Why?
|
Th1 Cells | 1 | 2010 | 1037 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2711 | 0.020 |
Why?
|
Natural Cytotoxicity Triggering Receptor 1 | 1 | 2004 | 29 | 0.020 |
Why?
|
Syndecans | 1 | 2004 | 75 | 0.020 |
Why?
|
Receptors, Natural Killer Cell | 1 | 2004 | 57 | 0.020 |
Why?
|
Tea | 1 | 2006 | 287 | 0.010 |
Why?
|
RNA | 1 | 2014 | 2721 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.010 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2004 | 95 | 0.010 |
Why?
|
Phytotherapy | 1 | 2006 | 296 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2052 | 0.010 |
Why?
|
Bone Marrow Neoplasms | 1 | 2004 | 101 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1134 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2009 | 1254 | 0.010 |
Why?
|
Pleural Effusion, Malignant | 1 | 2004 | 106 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2012 | 2058 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2911 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5794 | 0.010 |
Why?
|
Isoenzymes | 1 | 2007 | 1688 | 0.010 |
Why?
|
GPI-Linked Proteins | 1 | 2004 | 468 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4735 | 0.010 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2008 | 499 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6086 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2009 | 1929 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4509 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3026 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 803 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74055 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2009 | 4808 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4413 | 0.010 |
Why?
|
Transfection | 1 | 2009 | 5776 | 0.010 |
Why?
|
DNA | 1 | 2014 | 7208 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13445 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2004 | 1351 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2010 | 2819 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2413 | 0.010 |
Why?
|
Peptides | 1 | 2012 | 4338 | 0.010 |
Why?
|
Neoplasms | 1 | 2009 | 22083 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4116 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 17639 | 0.010 |
Why?
|
Cell Membrane | 1 | 2009 | 3685 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12653 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2011 | 3541 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2010 | 4430 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11070 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6525 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39947 | 0.010 |
Why?
|
Stem Cells | 1 | 2010 | 3522 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4168 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39078 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6297 | 0.010 |
Why?
|
Antigens, CD | 1 | 2004 | 4000 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3701 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6894 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 41366 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2008 | 22121 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 80430 | 0.010 |
Why?
|